Jose Gomez, MD
Undersea and Hyperbaric Medicine · Calhoun, GANPI 1447319975
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,330 of the $1,488 with a category attached, or 89.3%. 20 manufacturers reported payments, led by Organogenesis Inc. at 31.5% of the total.
Across 71 payments — averaging $20.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$469
- Stryker$182
- Polymedics Innovations Inc.$141
- Smith+Nephew$132
- Triad Life Sciences Inc.$101
- KCI USA, Inc.$79
- plus $385 from 14 others
What the payments were for
- Speaking & faculty fees$654%
- Travel & lodging$936%
- Food & beverage$1,33089%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 28 | $469 |
| Stryker | 2 | $182 |
| Polymedics Innovations Inc. | 5 | $141 |
| Smith+Nephew | 8 | $132 |
| Triad Life Sciences Inc. | 1 | $101 |
| KCI USA, Inc. | 4 | $79 |
| Convatec Inc. | 3 | $53 |
| ETS Wound Care LLC | 4 | $46 |
| Hollister Incorporated | 2 | $44 |
| AbbVie(2 entities) | 3 | $38 |
| Melinta Therapeutics, LLC | 2 | $33 |
| Abiomed | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Next Science LLC | 1 | $21 |
| Hydrofera LLC | 1 | $19 |
| Coloplast | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Reapplix Inc. | 1 | $15 |
| Bioventus LLC | 1 | $15 |
| Lifenet Health | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIA 3$161
- InnovaMatrix AC$101
How this compares
Too few undersea and hyperbaric medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Linezolid | 24 | $1,079 |
| Ciprofloxacin Hcl | 63 | $282 |
| Doxycycline Hyclate | 53 | $260 |
| Levofloxacin | 73 | $226 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $97 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $84 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Calhoun
- Belinda MarcusNewnan$26K
- Dana ConnerBlairsville$4K
- Norman McCullochWinder$2K
- Ricardo DuranRoswell$2K
- William LagalyAthens$2K
- Daniel BelessSandy Springs$955
- John SpenceVidalia$569
- John McGlynnMarietta$456
- Helen GellyMarietta$439
- Martin LynchRome$419
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.